Market Research Report
Structural Heart Devices Market by Product, Age Group, and Indication (Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, and Aortic Valve Stenosis) - Global Opportunity Analysis and Industry Forecast, 2014-2022
|Published by||Allied Market Research||Product code||676765|
|Published||Content info||274 Pages
Delivery time: 2-3 business days
|Structural Heart Devices Market by Product, Age Group, and Indication (Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, and Aortic Valve Stenosis) - Global Opportunity Analysis and Industry Forecast, 2014-2022|
|Published: February 1, 2017||Content info: 274 Pages||
Structural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD), and Aortic Valve Stenosis) - Global Opportunity Analysis and Industry Forecast, 2014-2022.
Structural heart disease refers to cardiac defects that are congenital in nature and can also be acquired through wear & tear of heart valves or chambers of the heart. Rapid advancements in the medical field have replaced the open heart surgical procedures with non-surgical minimally invasive procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR).
Currently, the global structural heart devices market is growing at a steady pace owing to the rise in incidence of structural heart diseases (aortic stenosis and mitral regurgitation) and development of minimally invasive technologies. According to the Micro Interventional Devices, Inc., about 60 million people in the U.S. suffer from structural heart defects. Moreover, as per the National Heart, Lung and Blood Institute, more than 35,000 babies are born with congenital heart defects in the U.S. These estimates are expected to boost the demand for structural heart devices during the forecast period. High cost of surgeries, risks associated with these surgeries, and lack of skilled cardiologists restrict this market growth. However, emerging markets (India and China) and increase in demand for structural heart procedures are expected to provide lucrative opportunities to the key players. The structural heart devices market is projected to reach $12,076 million by 2022 from $6,006 million in 2015, growing at a CAGR of 10.5% from 2016 to 2022.
The report segments the market based on product type, indication, age group, and geography. Based on product type, the market is bifurcated into repair devices (annuloplasty rings, heart valve balloons, and occluders) and replacement valves (mechanical and tissue heart valves]. Based on indication, it is divided into atrial septal defect (ASD), patent foramen ovale (PFO), and ventricular septal defect (VSD), aortic valve stenosis, and others. In terms of age group, it is further categorized as pediatrics and adults. The pediatrics' age group is segmented into newborns (0-5 months), infants (6 months to 12 months), toddlers (1-2 years), preschoolers (3-5 years), school-aged children (6-12 years), and adolescents (13-18 years). The adult age group market is further segmented into young adults (19-24 years), adulthood (25-39 years), middle-aged (40-59 years), older people/old age (60-84 years), and very old (85+ years). Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Age Group
Chapter: 1 INTRODUCTION
Chapter: 2 EXECUTIVE SUMMARY
Chapter: 3 MARKET OVERVIEW
Chapter: 4 STRUCTURAL HEART DEVICES MARKET, BY PRODUCT
Chapter: 5 STRUCTURAL HEART DEVICES MARKET, BY AGE GROUP
Chapter: 6 STRUCTURAL HEART DEVICES MARKET, BY INDICATION
Chapter: 7 STRUCTURAL HEART DEVICES MARKET, BY GEOGRAPHY
Chapter: 8 COMPANY PROFILES